Fluoroquinolone prophylaxis during neutropenia: what can we expect nowadays?

Clin Microbiol Infect. 2018 Jul;24(7):678-679. doi: 10.1016/j.cmi.2018.02.031. Epub 2018 Mar 13.

Authors

M Mikulska¹, C Cordonnier²

Affiliations

¹ Division of Infectious Diseases, University of Genoa (DISSAL) and Ospedale Policlinico San Martino, Genoa, Italy. Electronic address: [email protected].
² Department of Haematology, Henri Mondor Teaching Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris-Est-Créteil, Créteil, France.

PMID: 29549060
DOI: 10.1016/j.cmi.2018.02.031

No abstract available

Publication types

Letter

MeSH terms

Antibiotic Prophylaxis*
Disease Management
Drug Resistance, Microbial
Fluoroquinolones / therapeutic use*
Hematologic Neoplasms / complications
Hematologic Neoplasms / therapy
Humans
Neutropenia / complications*
Neutropenia / etiology
Opportunistic Infections / etiology*
Opportunistic Infections / prevention & control*
Outcome Assessment, Health Care

Substances

Fluoroquinolones